- Home
- MNSB vs THTX Comparison
MNSB vs THTX Comparison
Compare MNSB & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNSB
- THTX
- Stock Information
- Founded
- MNSB 2003
- THTX 1993
- Country
- MNSB United States
- THTX Canada
- Employees
- MNSB N/A
- THTX N/A
- Industry
- MNSB Major Banks
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- MNSB Finance
- THTX Health Care
- Exchange
- MNSB Nasdaq
- THTX Nasdaq
- Market Cap
- MNSB 170.1M
- THTX 144.8M
- IPO Year
- MNSB N/A
- THTX N/A
- Fundamental
- Price
- MNSB $21.64
- THTX $3.30
- Analyst Decision
- MNSB
- THTX Hold
- Analyst Count
- MNSB 0
- THTX 1
- Target Price
- MNSB N/A
- THTX N/A
- AVG Volume (30 Days)
- MNSB 14.5K
- THTX 340.1K
- Earning Date
- MNSB 10-27-2025
- THTX 10-09-2025
- Dividend Yield
- MNSB 1.85%
- THTX N/A
- EPS Growth
- MNSB N/A
- THTX N/A
- EPS
- MNSB N/A
- THTX N/A
- Revenue
- MNSB $64,604,000.00
- THTX $84,378,000.00
- Revenue This Year
- MNSB $23.19
- THTX N/A
- Revenue Next Year
- MNSB $2.92
- THTX $13.76
- P/E Ratio
- MNSB N/A
- THTX N/A
- Revenue Growth
- MNSB N/A
- THTX 2.19
- 52 Week Low
- MNSB $15.00
- THTX $1.12
- 52 Week High
- MNSB $22.98
- THTX $3.29
- Technical
- Relative Strength Index (RSI)
- MNSB 48.90
- THTX 75.09
- Support Level
- MNSB $21.09
- THTX $3.18
- Resistance Level
- MNSB $22.00
- THTX $3.27
- Average True Range (ATR)
- MNSB 0.28
- THTX 0.02
- MACD
- MNSB -0.17
- THTX -0.00
- Stochastic Oscillator
- MNSB 29.10
- THTX 91.60
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.